Director
H. Edward Fleming, Jr., M.D.
H. Edward Fleming, Jr., M.D., has served on our Board of Directors since June 2021. He is a Senior Partner at McKinsey, serving as global leader of their R&D practice. Edd joined McKinsey in 1997 where he has worked with healthcare companies of all sizes to improve their performance. He earned his B.A. in Chemistry from Harvard University, his M.D. from Vanderbilt University, and completed internal medicine training at Johns Hopkins Hospital and subspecialty training in pulmonary and critical care medicine at the University of California, San Francisco. Edd serves on the Board of Visitors for Vanderbilt’s School of Basic Sciences.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.